A randomized, multicenter, parallel-group, open-label study to assess the efficacy and safety of enteric-coated mycophenolate sodium (EC-MPS, myfortic®) versus continuation of previous therapy in patients with proliferative lupus nephritis on standard maintenance therapy
Phase of Trial: Phase III
Latest Information Update: 01 Jun 2011
At a glance
- Drugs Mycophenolate sodium; Prednisone
- Indications Lupus nephritis
- Focus Therapeutic Use
- Acronyms MyLupus
- Sponsors Novartis Pharma A.G.
- 01 Jun 2011 New Source Identified - European Clinical Trials Database.
- 05 Nov 2010 New trial record.